#ampligen

Live, measured metrics for the hashtag #ampligen from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #ampligen

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$110.68/ year · 8-character #name
Claim #ampligen — $110.68/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
3
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 3
0
Avg reactions / post
Mastodon · last 3

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-27 16:51 UTC
0
07-21
0
07-22
0
07-23
0
07-24
0
07-25
0
07-26
0
07-27

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-27 16:51 UTC

No related tags with measured usage found for #ampligen.

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-27 16:51 UTC

Everything below is measured over the latest 3 public posts (spanning ~5351 hours).

Posting hours (UTC)

00:0012:0023:00

Languages: English (3)

Avg boosts / post: 2.3

Top of the latest posts

  • Press release: AIM ImmunoTech Completes Treatment of Last Subject in Phase 2 Study Evaluating #Ampligen® for the Treatment of #PostCOVID Conditions https://www.globenewswire.com/news-release/2023/11/21/2784288/29489/en/AIM-ImmunoTech-Comple

    Tom Kindlon@[email protected]♥ 0↻ 32023-11-22 13:07 UTCView post →

  • Transcript: Q2 2023 AIM ImmunoTech Inc Earnings Call (Aug 16) https://finance.yahoo.com/news/q2-2023-aim-immunotech-inc-040749819.html This is the company that owns #Ampligen. There is quite a bit of discussion about the ongoing placebo-con

    Tom Kindlon@[email protected]♥ 0↻ 22023-08-16 17:11 UTCView post →

  • AIM ImmunoTech Announces Central IRB Approval of Phase 2 Study Protocol Evaluating Ampligen® for the Treatment of Post-COVID Conditions “The AMP-518 clinical trial is a two-arm, randomized, double-blind, placebo-controlled, multicenter stud

    Tom Kindlon@[email protected]♥ 0↻ 22023-04-13 13:59 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/ampligen